Clinical Trials Search

Find upcoming clinical trial events for your portfolio.

NCT IDTitleStatusPrimary Completion DatePhasesCompaniesStart DateCompletion Date
NCT03368742Microdystrophin Gene Transfer Study in Adolescents and Children With DMDACTIVE_NOT_RECRUITING2026-10-15PHASE1, PHASE22017-12-062026-10-15
NCT06517875Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent MyelofibrosisRECRUITING2026-10-14PHASE22025-02-282026-11-13
NCT05372354A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaRECRUITING2026-10-12PHASE1, PHASE22022-10-182026-10-12
NCT06995820A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.RECRUITING2026-10-12PHASE12025-06-062026-10-12
NCT06616974A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)RECRUITING2026-10-09PHASE22024-10-082026-11-20
NCT06959225Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)RECRUITING2026-10-09PHASE32025-06-232027-07-11
NCT06749457A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)RECRUITING2026-10-09PHASE1, PHASE22024-12-302027-07-06
NCT05925803Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)RECRUITING2026-10-09PHASE32023-11-082027-12-31
NCT06958211Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)RECRUITING2026-10-09PHASE32025-06-122027-07-11
NCT06616194A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent MigraineRECRUITING2026-10-08PHASE32024-11-152027-12-02
NCT05136677A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese ParticipantsACTIVE_NOT_RECRUITING2026-10-07PHASE22022-01-252026-10-08
NCT05831111A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsACTIVE_NOT_RECRUITING2026-10-07PHASE12023-04-052026-10-07
NCT02612454Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)ACTIVE_NOT_RECRUITING2026-10-07PHASE32015-10-152026-10-07
NCT06512883A Trial to Investigate Benralizumab in Children With Eosinophilic DiseasesRECRUITING2026-10-06PHASE32025-04-172027-12-29
NCT06200207A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationRECRUITING2026-10-05PHASE32024-04-012027-01-12
NCT05164094A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and AdultsACTIVE_NOT_RECRUITING2026-10-05PHASE1, PHASE22021-12-282026-10-05
NCT06713369AZD5305 hADME in Patients With Advanced Solid MalignanciesRECRUITING2026-10-02PHASE12025-04-022026-10-02
NCT07098806Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal MetastasesRECRUITING2026-10-02PHASE12025-07-022031-10-02
NCT04812925A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients with Primary Immune ThrombocytopeniaACTIVE_NOT_RECRUITING2026-10-01PHASE32021-11-172026-10-01
NCT05642455SPEARHEAD-3 Pediatric StudyRECRUITING2026-10-01PHASE1, PHASE22023-09-012038-07-30
NCT06151964A Trial to Learn How Safe AZD9550 is in People With or Without Type 2 Diabetes Who Are Overweight or ObeseACTIVE_NOT_RECRUITING2026-10-01PHASE1, PHASE22023-09-292026-10-01
NCT05230537A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular DegenerationACTIVE_NOT_RECRUITING2026-10-01PHASE22022-02-172026-10-02
NCT05908084To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring HemodialysisRECRUITING2026-10PHASE32023-09-072027-10
NCT06560632Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-10PHASE12024-09-172028-12
NCT06727552A Study of Barzolvolimab in Patients With Atopic DermatitisRECRUITING2026-10PHASE22025-01-072027-05
NCT06842186A Phase 1 Study of WVE-007 in Adults Living with Overweight or ObesityRECRUITING2026-10PHASE12025-01-312026-10
NCT06698458Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerRECRUITING2026-10NA2025-06-172026-12
NCT06445023A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaRECRUITING2026-10PHASE32024-07-112027-04
NCT06119581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRECRUITING2026-10PHASE32023-12-212029-10
NCT05983250LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFRECRUITING2026-10PHASE32024-01-102028-10
NCT06895343A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcutaneous Doses of ABBV-701 in Healthy Adult Western and Asian ParticipantsRECRUITING2026-10PHASE12025-04-032026-10
NCT06603324Analysis of Paediatric Treatments With multiFiltratePRONOT_YET_RECRUITING2026-10NA2025-102026-12
NCT05787587A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsRECRUITING2026-10PHASE12023-04-052027-05
NCT06325566Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainRECRUITING2026-10PHASE32024-07-032027-10
NCT04777994Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsRECRUITING2026-10PHASE12021-03-092026-10
NCT06857942A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)RECRUITING2026-10PHASE42025-03-192026-10
NCT05432583A Clinical Trial in Healthy Volunteers and Volunteers with Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination with an Investigational Vaccine Designed to Prevent Genital Herpes LesionsRECRUITING2026-10PHASE12022-12-082026-10
NCT07152002A Study of LY4064912 in Healthy Participants and With Overweight or ObesityRECRUITING2026-10PHASE12025-08-282026-10
NCT07059312A Phase 1 Study of JADE101 in Healthy ParticipantsRECRUITING2026-10PHASE12025-08-172026-10
NCT07046494Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderRECRUITING2026-10PHASE22025-07-252026-12
NCT06455202A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)RECRUITING2026-10PHASE32024-07-192027-04
NCT05395481A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)RECRUITING2026-10PHASE12022-06-082026-10
NCT07161635Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLsNOT_YET_RECRUITING2026-10NA2025-102026-10
NCT06897358Leniolisib for Immune Dysregulation in CVIDRECRUITING2026-10PHASE22025-02-122026-10
NCT05407636Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMDRECRUITING2026-10PHASE32022-01-132027-11
NCT06798896RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset SeizuresRECRUITING2026-10PHASE22024-12-302026-10
NCT06107413Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and BevacizumabRECRUITING2026-10PHASE22023-11-122026-10
NCT06338995A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)RECRUITING2026-10PHASE32024-04-292027-02
NCT05747924Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)ACTIVE_NOT_RECRUITING2026-10PHASE1, PHASE22023-04-042027-04
NCT07090161Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionNOT_YET_RECRUITING2026-10PHASE22025-07-282026-11
NCT06910358Study of Bitopertin in Participants With EPP or XLP (APOLLO)RECRUITING2026-10PHASE32025-04-042026-11
NCT06553768Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)RECRUITING2026-10PHASE32024-10-142027-02
NCT06560645A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationRECRUITING2026-10PHASE12024-11-042027-04
NCT07054281UNITY VCS Vitreoretinal SurgeryNOT_YET_RECRUITING2026-10NA2026-012027-02
NCT07027527An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic DermatitisRECRUITING2026-10PHASE12025-06-042027-10
NCT06173505Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLCRECRUITING2026-10PHASE1, PHASE22023-12-272027-10
NCT06683742A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56ACTIVE_NOT_RECRUITING2026-10PHASE32024-11-272027-10
NCT06335173A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)ACTIVE_NOT_RECRUITING2026-10PHASE22024-02-292026-10
NCT05804669A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's SyndromeRECRUITING2026-10PHASE1, PHASE22023-10-122026-10
NCT07155031Biotin-Acridine Red Cell Exchange KineticsNOT_YET_RECRUITING2026-09-30PHASE22025-10-152026-12-15
NCT04961567A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusRECRUITING2026-09-30PHASE32021-07-162027-03-16
NCT05138133Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus NephritisRECRUITING2026-09-30PHASE32022-02-152028-07-07
NCT07025304Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in ChinaRECRUITING2026-09-30NA2025-07-022028-06-30
NCT06987513RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or OverweightRECRUITING2026-09-30PHASE22025-05-152026-09-30
NCT06534892An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 StudyRECRUITING2026-09-30PHASE32024-08-012026-09-30
NCT04039607A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular CarcinomaACTIVE_NOT_RECRUITING2026-09-30PHASE32019-09-302026-09-30
NCT06716853A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment, with Single Dose of Temferon, of Patients Suffering from Metastatic Renal Cell CarcinomaRECRUITING2026-09-30PHASE1, PHASE22024-10-222026-09-30
NCT05059522Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are ClosingACTIVE_NOT_RECRUITING2026-09-30PHASE32021-09-292026-09-30
NCT05318105Ultrafiltration Versus IV Diuretics in Worsening Heart FailureRECRUITING2026-09-30NA2022-06-282026-12-31
NCT06280209A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular DystrophyRECRUITING2026-09-30PHASE1, PHASE22024-01-032026-09-30
NCT05827614Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene AmplificationsRECRUITING2026-09-30PHASE12023-03-242027-03-31
NCT06392386A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia GravisRECRUITING2026-09-30PHASE2, PHASE32024-06-282026-09-30
NCT06484114Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on TirzepatideACTIVE_NOT_RECRUITING2026-09-30NA2024-09-012027-09-30
NCT05888831A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-09-30PHASE1, PHASE22023-06-062026-09-30
NCT06254950A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative ColitisRECRUITING2026-09-30PHASE22024-03-292027-08-04
NCT04895241A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusRECRUITING2026-09-30PHASE32021-05-252027-03-16
NCT06100276Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)RECRUITING2026-09-30PHASE1, PHASE22024-08-012031-03-30
NCT06948773A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)RECRUITING2026-09-30NA2025-05-212026-09-30
NCT05896163A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.RECRUITING2026-09-28PHASE1, PHASE22023-08-302028-09-27
NCT05956626A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseRECRUITING2026-09-28PHASE2, PHASE32023-08-252026-09-28
NCT07143604A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2RECRUITING2026-09-28PHASE22025-08-292027-09-28
NCT05017012A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)ACTIVE_NOT_RECRUITING2026-09-26PHASE12021-09-212026-09-26
NCT05484206Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434RECRUITING2026-09-25PHASE12022-09-212027-04-30
NCT06951880A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy VolunteersNOT_YET_RECRUITING2026-09-24PHASE12025-06-272026-09-24
NCT04557449Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsACTIVE_NOT_RECRUITING2026-09-23PHASE22020-09-232027-11-23
NCT05995964A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic DermatitisRECRUITING2026-09-21PHASE22023-08-222026-12-14
NCT06660563A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)RECRUITING2026-09-21PHASE12024-10-222026-09-21
NCT06708299CardiolRx in Recurrent Pericarditis Following IL-1 Blocker CessationRECRUITING2026-09-21PHASE32025-04-072026-10-21
NCT06465186A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)RECRUITING2026-09-21PHASE22024-07-122026-09-21
NCT06613100Evaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerRECRUITING2026-09-19PHASE12024-11-252030-01-23
NCT06145373A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With EmicizumabRECRUITING2026-09-19PHASE42024-03-012029-11-30
NCT03162536A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)ACTIVE_NOT_RECRUITING2026-09-18PHASE1, PHASE22017-06-262026-09-18
NCT06233461A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseRECRUITING2026-09-18PHASE22024-03-052027-07-23
NCT07204964A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and AboveNOT_YET_RECRUITING2026-09-18PHASE22025-10-102026-09-18
NCT06671587iGlarLixi CGM Study in Chinese T2D Individuals After OADsRECRUITING2026-09-18PHASE42024-12-102026-09-18
NCT06082037A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft DysfunctionRECRUITING2026-09-17PHASE32023-10-102028-06-02
NCT06832410An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney TransplantRECRUITING2026-09-17PHASE32025-03-312027-09-17
NCT03423628A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerRECRUITING2026-09-16PHASE12018-04-022026-09-16
NCT06807463A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac DiseaseRECRUITING2026-09-15PHASE22025-03-312027-09-14
NCT04634877Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)ACTIVE_NOT_RECRUITING2026-09-15PHASE32021-01-102026-09-15
NCT05038735Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.ACTIVE_NOT_RECRUITING2026-09-15PHASE32021-12-172026-10-15
NCT06449378Transorbâ„¢ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral HerniaACTIVE_NOT_RECRUITING2026-09-15NA2024-07-022030-10-01
NCT05721222Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)RECRUITING2026-09-15PHASE1, PHASE22023-03-152026-12-31
NCT06637371A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate AsthmaRECRUITING2026-09-13PHASE12024-10-162026-10-25
NCT05662319A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe HemophiliaACTIVE_NOT_RECRUITING2026-09-12PHASE32023-02-012028-06-01
NCT07087795A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 DiabetesRECRUITING2026-09-12PHASE12025-07-012026-09-25
NCT07153159A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding WomenRECRUITING2026-09-12PHASE12025-08-072026-10-12
NCT06516965A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)RECRUITING2026-09-11PHASE32024-10-102027-06-02
NCT05521087A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasWITHDRAWN2026-09-11PHASE12025-12-262030-01-29
NCT05469360Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease ParticipantsRECRUITING2026-09-11PHASE12023-02-232028-01-02
NCT06079879A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)RECRUITING2026-09-10PHASE32023-12-312028-08-18
NCT05093972Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)NOT_YET_RECRUITING2026-09-10PHASE12026-04-072026-09-10
NCT03953300Benralizumab Airway Remodeling Study in Severe Eosinophilic AsthmaticsRECRUITING2026-09-09PHASE42019-10-172026-09-09
NCT05798117An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus ErythematosusACTIVE_NOT_RECRUITING2026-09-09PHASE1, PHASE22023-02-282026-09-09
NCT06006559A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue FeverRECRUITING2026-09-07PHASE22024-02-202026-09-07
NCT05754957A Study of Milvexian in Participants After a Recent Acute Coronary SyndromeRECRUITING2026-09-07PHASE32023-04-072026-12-09
NCT06730750A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid TumorsRECRUITING2026-09-05PHASE1, PHASE22025-02-122029-12-09
NCT04857372A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid TumorsACTIVE_NOT_RECRUITING2026-09-04PHASE12021-10-212026-09-04
NCT06734234A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney DiseaseRECRUITING2026-09-04PHASE12024-12-112026-09-04
NCT06118281ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackRECRUITING2026-09-03PHASE32024-06-252026-09-03
NCT07099898A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)RECRUITING2026-09-02PHASE32025-08-112028-09-11
NCT06245408A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom StateRECRUITING2026-09-02PHASE32024-04-082026-11-03
NCT04824092Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL PatientsACTIVE_NOT_RECRUITING2026-09-01PHASE32021-05-112027-11-01
NCT06717698A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseRECRUITING2026-09-01PHASE22024-12-022026-09-29
NCT06132256MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)RECRUITING2026-09PHASE22023-12-112026-11
NCT06307626A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.RECRUITING2026-09PHASE32024-03-282027-09
NCT06381141A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple MyelomaACTIVE_NOT_RECRUITING2026-09PHASE12024-09-032027-03
NCT05303064Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderRECRUITING2026-09PHASE32022-06-302026-09
NCT05172726Tapinarof for the Treatment of Plaque Psoriasis in Pediatric SubjectsRECRUITING2026-09PHASE32021-12-022026-09
NCT06143956A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRECRUITING2026-09PHASE22023-11-172026-11
NCT06150183Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid TumorsRECRUITING2026-09PHASE12023-11-302026-09
NCT06568692A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerRECRUITING2026-09PHASE22024-10-022026-10
NCT06793371AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFRECRUITING2026-09PHASE22025-02-062026-09
NCT05536804A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesACTIVE_NOT_RECRUITING2026-09PHASE22023-02-082026-10
NCT02736656Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)ACTIVE_NOT_RECRUITING2026-09PHASE32016-02-022026-09
NCT06993610Tibulizumab Skin Healing and Inflammation Evaluation for Lasting DefenseRECRUITING2026-09PHASE22025-05-162027-03
NCT06138743Study of ARO-DM1 in Subjects With Type 1 Myotonic DystrophyRECRUITING2026-09PHASE1, PHASE22024-03-042026-09
NCT06742190A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor NeuropathyRECRUITING2026-09PHASE32024-12-182029-12
NCT06297603Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)RECRUITING2026-09PHASE32024-03-152026-10
NCT06868264C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCVRECRUITING2026-09PHASE32025-04-072026-12
NCT06569823Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy AdultsRECRUITING2026-09PHASE1, PHASE22024-06-172026-09
NCT06307613A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye DiseaseRECRUITING2026-09PHASE32024-03-272027-09
NCT07169851A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerNOT_YET_RECRUITING2026-09PHASE22025-102026-09
NCT05459181HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)NOT_YET_RECRUITING2026-09NA2025-122026-09
NCT07090330ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisRECRUITING2026-09PHASE22025-07-182027-05
NCT07024693DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyRECRUITING2026-09PHASE22025-072026-12
NCT07179055An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyeRECRUITING2026-09PHASE22025-102026-09
NCT06405633A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATDRECRUITING2026-09PHASE1, PHASE22024-07-192026-09
NCT06812325A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)RECRUITING2026-09PHASE32025-02-032026-12
NCT06830629A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseRECRUITING2026-09PHASE22025-02-052026-09
NCT06920901A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With AsthmaACTIVE_NOT_RECRUITING2026-09PHASE12025-03-272027-03
NCT05315700Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationRECRUITING2026-09PHASE1, PHASE22022-03-102027-09
NCT06100744A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabRECRUITING2026-09PHASE32024-07-082028-10
NCT04562870A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated MyelofibrosisACTIVE_NOT_RECRUITING2026-09PHASE22021-03-172026-09
NCT06334133Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesRECRUITING2026-09PHASE32024-06-142026-10
NCT07020923Monthly Dosing of Atacicept in IgANRECRUITING2026-09PHASE22025-05-292027-09
NCT06095986A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing CholangitisWITHDRAWN2026-09PHASE22025-062027-12
NCT06160752Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene AlterationsRECRUITING2026-09PHASE12023-11-222027-09
NCT05848011A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate CancerACTIVE_NOT_RECRUITING2026-09PHASE22023-09-282027-09
NCT05106491Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock PatientsNOT_YET_RECRUITING2026-09NA2025-092026-09
NCT06108219A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)ACTIVE_NOT_RECRUITING2026-09PHASE22023-10-252026-09
NCT05320198Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaRECRUITING2026-09PHASE1, PHASE22022-06-062026-09
NCT05592002Safety and Effectiveness of the Genio® bilAteral Stimulation for Treatment of Complete Concentric CollapsE and OSA.ACTIVE_NOT_RECRUITING2026-09NA2022-12-282028-09
NCT03845166A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsACTIVE_NOT_RECRUITING2026-08-31PHASE12019-03-202027-05-31
NCT05669482Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerACTIVE_NOT_RECRUITING2026-08-31PHASE1, PHASE22023-03-222027-08-31
NCT05107674A Study of NX-1607 in Adults With Advanced MalignanciesRECRUITING2026-08-31PHASE12021-09-292028-02-28
NCT06550895A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple MyelomaRECRUITING2026-08-31PHASE22024-09-162026-08-31
NCT05567406Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic TherapyRECRUITING2026-08-31PHASE22025-06-162026-08-31
NCT05743881A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 MonthsACTIVE_NOT_RECRUITING2026-08-31PHASE12023-02-152026-09-30
NCT02934568Ribociclib (LEE011) Rollover Study for Continued AccessRECRUITING2026-08-31PHASE22016-12-152026-09-01
NCT05884398A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCACTIVE_NOT_RECRUITING2026-08-31PHASE32023-08-312026-08-31
NCT06152575MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)RECRUITING2026-08-30PHASE32024-02-082027-12-30
NCT05739981Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal CancerRECRUITING2026-08-30PHASE1, PHASE22023-02-102028-01-30
NCT07047521A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy AdultsNOT_YET_RECRUITING2026-08-30PHASE32025-11-172027-07-30
NCT07161414A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care TherapyNOT_YET_RECRUITING2026-08-27PHASE12025-10-212028-03-28
NCT05757713Teplizumab in Pediatric Stage 2 Type 1 DiabetesACTIVE_NOT_RECRUITING2026-08-27PHASE42023-07-252026-08-27
NCT04699188Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationACTIVE_NOT_RECRUITING2026-08-26PHASE1, PHASE22021-02-242026-08-26
NCT07160257A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes MellitusRECRUITING2026-08-26PHASE12025-08-052026-12-13
NCT07211607I.V. Selonabant in Healthy Adult SubjectsRECRUITING2026-08-25PHASE12025-09-222026-08-25
NCT06984627A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' DiseaseRECRUITING2026-08-25PHASE22025-09-022026-09-23
NCT04711252A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseACTIVE_NOT_RECRUITING2026-08-24PHASE32021-01-282029-02-01
NCT05262400A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsACTIVE_NOT_RECRUITING2026-08-23PHASE1, PHASE22022-03-142026-08-23
NCT06797869A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyRECRUITING2026-08-21PHASE22025-01-292026-08-21
NCT04626635A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced CancersRECRUITING2026-08-19PHASE1, PHASE22020-12-212026-12-12
NCT05489211Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)RECRUITING2026-08-19PHASE22022-09-062026-08-19
NCT06659640A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)RECRUITING2026-08-19PHASE1, PHASE22024-11-112028-06-22
NCT05298423Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)ACTIVE_NOT_RECRUITING2026-08-19PHASE32022-05-032026-08-19
NCT04995523A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCRECRUITING2026-08-18PHASE1, PHASE22021-09-142028-03-16
NCT06655155A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic SclerosisRECRUITING2026-08-17PHASE22024-11-112027-06-14
NCT05639647Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative InfectionsRECRUITING2026-08-17PHASE22023-04-182026-08-17
NCT03974113Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or BACTIVE_NOT_RECRUITING2026-08-15PHASE32020-01-282026-12-15
NCT05444465Use of the REGENETENâ„¢ Bioinductive Implant System in High Grade Partial-thickness TearsRECRUITING2026-08-15NA2022-08-302028-06-30
NCT06433921A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 InclusiveRECRUITING2026-08-14PHASE12024-08-142026-08-14
NCT05267613Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.RECRUITING2026-08-14PHASE32022-07-012027-09-06
NCT06432764Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.RECRUITING2026-08-14PHASE12024-10-162026-08-14
NCT05168748CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic LeukemiaWITHDRAWN2026-08-13PHASE12023-01-242026-08-13
NCT05601752ADP-A2M4CD8 Monotherapy and in Combination with Nivolumab in HLA-A2+ Subjects with MAGE-A4 Positive Ovarian Cancer (SURPASS-3)ACTIVE_NOT_RECRUITING2026-08-12PHASE22023-06-262026-08-12
NCT06667141Phase 1 Study of ACR-2316 in Specific Advanced Solid TumorsRECRUITING2026-08-12PHASE12024-10-082026-12-12
NCT06147856A Dose-finding Study to Evaluate mRNA-3210 in Participants With PhenylketonuriaWITHDRAWN2026-08-10PHASE1, PHASE22024-03-292027-08-05
NCT06376045A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe AsthmaRECRUITING2026-08-10PHASE22024-05-242026-10-02
NCT06548360A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental VitiligoRECRUITING2026-08-10PHASE32025-01-242027-03-13
NCT05508906Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, or Everolimus in ER+, HER2- Breast CancerACTIVE_NOT_RECRUITING2026-08-09PHASE12022-08-312026-09-09
NCT07103148A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric PopulationRECRUITING2026-08-08PHASE32025-07-112029-10-11
NCT06691113A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal PolypsRECRUITING2026-08-07PHASE22024-12-162027-02-09
NCT07017179This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity/OverweightRECRUITING2026-08-06PHASE22025-05-202026-08-06
NCT07133828A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years OldRECRUITING2026-08-06PHASE12025-08-292026-08-06
NCT07112339A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 DiabetesRECRUITING2026-08-04PHASE42025-08-152028-08-31
NCT04133636A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple MyelomaRECRUITING2026-08-04PHASE22019-11-072028-01-17
NCT06557772A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac DiseaseRECRUITING2026-08-04PHASE22024-08-292029-04-10
NCT04929210A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseRECRUITING2026-08-04PHASE42021-08-302027-04-13
NCT06855160A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of AgeRECRUITING2026-08-03PHASE32025-04-172026-12-24
NCT07205159A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.NOT_YET_RECRUITING2026-08-03PHASE12025-10-152026-12-12
NCT05577182Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced MalignanciesACTIVE_NOT_RECRUITING2026-08-03PHASE12023-01-052026-08-03
NCT05920135First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKIACTIVE_NOT_RECRUITING2026-08-01PHASE1, PHASE22023-09-112028-08-01
NCT05683457A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.RECRUITING2026-08-01PHASE22023-04-052026-08-01
NCT04899310A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic AcidemiaRECRUITING2026-08-01PHASE1, PHASE22021-08-062028-08-01
NCT06418711ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation SuspensionRECRUITING2026-08-01PHASE32024-09-112028-12-01
NCT06455059Interventional Study of Vosoritide for the Treatment of Children with HypochondroplasiaENROLLING_BY_INVITATION2026-08-01PHASE32024-06-062026-08-01
NCT06727565Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma.RECRUITING2026-08PHASE22025-02-182026-08
NCT01983241Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)ACTIVE_NOT_RECRUITING2026-08PHASE32013-112027-01
NCT02099058A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-08PHASE12014-01-152026-08
NCT05517447Extension Study to Assess Batoclimab in Participants With Thyroid Eye DiseaseRECRUITING2026-08PHASE32022-11-062026-08
NCT06668064A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56ACTIVE_NOT_RECRUITING2026-08PHASE32024-10-222027-08
NCT06669754Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAERECRUITING2026-08PHASE32024-12-012026-08
NCT03539744A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.ACTIVE_NOT_RECRUITING2026-08PHASE32018-10-222027-11
NCT07021547A Study of LY3867070 in Healthy ParticipantsRECRUITING2026-08PHASE12025-05-272026-08
NCT06667453A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1RECRUITING2026-08PHASE22024-12-102026-08
NCT07032597A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult ParticipantsACTIVE_NOT_RECRUITING2026-08PHASE32025-05-262026-10
NCT07011966ASV Therapy for InsomniaNOT_YET_RECRUITING2026-08NA2025-082026-08
NCT06050122Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin SyndromeACTIVE_NOT_RECRUITING2026-08PHASE32024-03-172026-08
NCT06001788Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRECRUITING2026-08PHASE12024-02-222027-08
NCT06389136A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabRECRUITING2026-08PHASE32024-06-122027-03
NCT06579300A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088SUSPENDED2026-08PHASE12024-09-042026-08
NCT05211570AB8939 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRECRUITING2026-08PHASE1, PHASE22022-06-012026-12
NCT06909214A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)RECRUITING2026-08PHASE42025-04-172027-05
NCT05995340ELAPR002f Injectable Gel in the Treatment of Atrophic Acne ScarsACTIVE_NOT_RECRUITING2026-08PHASE32023-11-212026-08
NCT07122583A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite SystemRECRUITING2026-08PHASE42025-07-222026-08
NCT05580562ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)RECRUITING2026-08PHASE32023-01-232026-08
NCT06260722Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)ACTIVE_NOT_RECRUITING2026-08PHASE32024-02-212027-01
NCT06775379A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderRECRUITING2026-08PHASE32024-12-202026-10
NCT07108036A Study to Assess Anktiva in Patients With Long Covid-19.NOT_YET_RECRUITING2026-08PHASE22025-082026-08
NCT06656416ALTO-100 in Bipolar Disorder With Depression (BD-D)RECRUITING2026-08PHASE22024-10-022026-10
NCT03328078CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)RECRUITING2026-08PHASE1, PHASE22017-12-282026-10
NCT06600724Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUsRECRUITING2026-08NA2024-08-272026-08
NCT06817356A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderRECRUITING2026-08PHASE22025-02-062026-08
NCT05291091Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)ACTIVE_NOT_RECRUITING2026-08PHASE22022-07-062026-08
NCT07165002A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver ImpairmentNOT_YET_RECRUITING2026-08PHASE12025-102026-08
NCT05611931Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaRECRUITING2026-08PHASE32023-04-182028-01
NCT05308264Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)RECRUITING2026-08PHASE1, PHASE22022-09-122026-12
NCT07011706ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic DermatitisRECRUITING2026-08PHASE22025-05-302026-10
NCT06906341Relacorilant in Combination With Nab-paclitaxel and Bevacizumab in Advanced, Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube CancerRECRUITING2026-08PHASE22025-04-112026-12
NCT07186595A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial AppearanceNOT_YET_RECRUITING2026-08PHASE42025-09-232026-08
NCT05802329Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)RECRUITING2026-07-31PHASE12024-01-132026-07-31
NCT06639828Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver ImagingRECRUITING2026-07-31PHASE42025-01-202026-10-31
NCT07038473Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)NOT_YET_RECRUITING2026-07-31NA2025-08-312026-09-01
NCT05382325A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)ACTIVE_NOT_RECRUITING2026-07-31PHASE12022-06-162026-07-31
NCT05025605Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar DisorderRECRUITING2026-07-31PHASE12021-08-272026-12-31
NCT06942910A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High ProteinuriaRECRUITING2026-07-31PHASE22025-05-072026-07-31
NCT04729907A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)ACTIVE_NOT_RECRUITING2026-07-31PHASE32021-04-192026-07-31
NCT04379596Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)RECRUITING2026-07-30PHASE22020-06-032026-07-30
NCT04433065TTVR Early Feasibility StudyRECRUITING2026-07-30NA2020-10-202031-07-30
NCT06669234Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy AdultsRECRUITING2026-07-30PHASE12025-03-062026-07-30
NCT06953466Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeRECRUITING2026-07-30PHASE2, PHASE32025-072026-07-30
NCT07015437A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1NOT_YET_RECRUITING2026-07-30PHASE22025-07-152026-10-15
NCT06067230A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk AdultsACTIVE_NOT_RECRUITING2026-07-30PHASE32023-10-062026-07-30
NCT05261139EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseaseRECRUITING2026-07-30PHASE32022-03-072026-07-30
NCT06908304A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCNOT_YET_RECRUITING2026-07-29PHASE32025-11-032027-07-29
NCT05895786A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]RECRUITING2026-07-28PHASE32023-05-202026-07-28
NCT06551142A Study of GSK5764227 in Participants With Advanced Solid TumorsRECRUITING2026-07-27PHASE12024-09-302027-03-19
NCT06291857A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination VaccineACTIVE_NOT_RECRUITING2026-07-26PHASE32024-12-092026-09-30
NCT04036435Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With PsoriasisACTIVE_NOT_RECRUITING2026-07-25PHASE32019-08-122026-07-26
NCT06629779A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.RECRUITING2026-07-24PHASE32024-10-222028-11-30
NCT05412030A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy InfantsACTIVE_NOT_RECRUITING2026-07-23PHASE22022-06-162026-07-23
NCT06630117A Study of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older (60 to 79 Years Inclusive) Participants (V330-001)RECRUITING2026-07-23PHASE12024-03-012027-01-25
NCT06608901A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced HypotensionRECRUITING2026-07-23PHASE22025-05-052026-10-19
NCT04123366Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)ACTIVE_NOT_RECRUITING2026-07-23PHASE22019-11-182026-07-23
NCT05879822A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor NaiveACTIVE_NOT_RECRUITING2026-07-22PHASE22023-10-302026-07-22
NCT06585462Single and Multiple Ascending Dose Study of AMG 513 in Participants With ObesityRECRUITING2026-07-22PHASE12024-09-092026-07-22
NCT07029568A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy PeopleRECRUITING2026-07-22PHASE12025-06-132026-07-22
NCT04846920A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)ACTIVE_NOT_RECRUITING2026-07-21PHASE12021-06-142026-07-21
NCT05468697A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)ACTIVE_NOT_RECRUITING2026-07-21PHASE1, PHASE22022-08-102026-07-21
NCT06899061Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of SaruparibRECRUITING2026-07-21PHASE12025-03-252026-11-19
NCT06058156Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic DermatitisACTIVE_NOT_RECRUITING2026-07-21PHASE22023-11-092026-08-18
NCT05316220A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative ColitisWITHDRAWN2026-07-19PHASE32025-09-152026-07-19
NCT06052267A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsRECRUITING2026-07-17PHASE32023-08-302026-07-17
NCT06385080A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck CancerRECRUITING2026-07-17PHASE1, PHASE22024-04-222028-04-17
NCT07049328HCW9302 (Interleukin-2 Fusion Protein) for Alopecia AreataRECRUITING2026-07-16PHASE12025-08-162026-12-15
NCT05583227Efficacy and Safety of Tezepelumab in Patients With Eosinophilic EsophagitisACTIVE_NOT_RECRUITING2026-07-16PHASE32022-11-102027-03-25
NCT06539481Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.RECRUITING2026-07-15PHASE42024-08-312028-10-31
NCT06748053A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled AsthmaRECRUITING2026-07-15PHASE22025-02-102027-01-14
NCT06387342Namodenoson Treatment of Advanced Pancreatic CancerRECRUITING2026-07-15PHASE22024-11-102026-12-15
NCT06317311A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial CancerACTIVE_NOT_RECRUITING2026-07-15PHASE22024-05-072027-08-31
NCT06881251A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)RECRUITING2026-07-15PHASE22025-02-262026-08-14
NCT06548100A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)ACTIVE_NOT_RECRUITING2026-07-14PHASE32024-12-162026-11-03
NCT06188507A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy ParticipantsSUSPENDED2026-07-14PHASE12024-01-122026-07-14
NCT06832618A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic DermatitisRECRUITING2026-07-13PHASE32025-06-172028-05-18
NCT05630352A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and ChildrenWITHDRAWN2026-07-13PHASE12025-01-062026-07-13
NCT05039840Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusRECRUITING2026-07-10PHASE22021-11-102026-10-02
NCT06112743A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic CardiomyopathyACTIVE_NOT_RECRUITING2026-07-09PHASE42024-01-242026-07-09
NCT06851858Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor AgonistRECRUITING2026-07-08PHASE22025-03-122026-07-08
NCT06194448To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR MutationsACTIVE_NOT_RECRUITING2026-07-07PHASE22024-04-212027-07-07
NCT04380636Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)ACTIVE_NOT_RECRUITING2026-07-06PHASE32020-07-062027-02-15
NCT06088199A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque PsoriasisRECRUITING2026-07-06PHASE32023-10-242026-07-06
NCT06864169A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)RECRUITING2026-07-06PHASE22025-04-012029-01-04
NCT04784715Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)ACTIVE_NOT_RECRUITING2026-07-06PHASE32021-04-262029-12-30
NCT06567782A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon CancerRECRUITING2026-07-06PHASE22025-02-172028-06-15
NCT06122779Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)RECRUITING2026-07-03PHASE22023-11-072026-07-03
NCT06843408A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHDRECRUITING2026-07-03PHASE1, PHASE22025-06-252027-12-31
NCT05702229Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRECRUITING2026-07-03PHASE22023-01-162027-07-01
NCT05966480Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusACTIVE_NOT_RECRUITING2026-07-01PHASE22023-06-262027-09-01
NCT06693895A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of AgeRECRUITING2026-07-01PHASE32024-11-262026-11-23
NCT04919980TVMR With the Innovalve System Trial - Early Feasibility StudyRECRUITING2026-07-01NA2022-09-012031-07-01
NCT05479812Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid TumorsRECRUITING2026-07-01PHASE12022-05-202026-07-31
NCT06617429Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)ACTIVE_NOT_RECRUITING2026-07PHASE32024-12-032027-11
NCT03891446Long-term Safety and Efficacy Extension Trial of Bimatoprost SRACTIVE_NOT_RECRUITING2026-07PHASE32019-03-272026-08
NCT06848348Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainRECRUITING2026-07PHASE22025-02-212026-08
NCT06366464A Study of Pitolisant in Patients With Prader-Willi SyndromeRECRUITING2026-07PHASE32024-05-282027-07
NCT04544267Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of AgeSUSPENDED2026-07PHASE32020-09-152026-07
NCT06750432PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)RECRUITING2026-07PHASE12024-12-132026-12
NCT06921759A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot DermatitisRECRUITING2026-07PHASE32025-04-212026-09
NCT05839730Fast Induced Remodeling in Heart Failure With Preserved Ejection FractionRECRUITING2026-07NA2024-09-112027-07
NCT06606106A Study of LY3537031 in Overweight, Obese, and Healthy ParticipantsRECRUITING2026-07PHASE12024-09-052026-07
NCT06783621A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica ProductsRECRUITING2026-07PHASE42025-01-162026-07
NCT06101329Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)ACTIVE_NOT_RECRUITING2026-07PHASE22023-11-172028-01
NCT05082571Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney DiseaseWITHDRAWN2026-07PHASE32025-012026-10
NCT07054684Study of BHV-1400 in IgA NephropathyRECRUITING2026-07PHASE12025-07-302026-07
NCT06566092Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult ParticipantsRECRUITING2026-07PHASE12024-03-282028-07
NCT06689839Trial of the F2 Filter and Delivery System for Embolic Protection During TAVRNOT_YET_RECRUITING2026-07NA2025-03-012026-10
NCT05720117Study of PYX-201 in Solid TumorsRECRUITING2026-07PHASE12023-03-142027-05
NCT06959121CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial FibrillationNOT_YET_RECRUITING2026-07NA2025-072027-01
NCT07092813Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in AdolescentsNOT_YET_RECRUITING2026-07PHASE12025-092026-07
NCT05082584Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating AgentsWITHDRAWN2026-07PHASE32025-012026-10
NCT06521463SIMPLAAFY Clinical TrialRECRUITING2026-07NA2024-10-012027-01
NCT07123727A Study to Examine Anktiva for the Treatment of COVID-19.RECRUITING2026-07PHASE22025-092026-07
NCT07010471A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineRECRUITING2026-07PHASE32025-07-092027-07
NCT06937203Study of ARO-ALK7 in Adult Volunteers With Obesity With and Without Type 2 Diabetes MellitusRECRUITING2026-07PHASE1, PHASE22025-05-072026-07
NCT06056297A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsRECRUITING2026-07PHASE32024-06-062026-08
NCT07158437Phase 1 Study of SL-325 in Healthy VolunteersRECRUITING2026-07PHASE12025-092026-07
NCT06481891A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyRECRUITING2026-07PHASE32024-09-242026-08
NCT05005403Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or BevacizumabRECRUITING2026-07PHASE12021-11-012027-06
NCT06188585Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal BleedingRECRUITING2026-07NA2024-06-212026-08
NCT06425159A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic SeizuresRECRUITING2026-07PHASE2, PHASE32024-06-202027-07
NCT07155668A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)RECRUITING2026-07PHASE32025-07-012026-11
NCT06562907Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)RECRUITING2026-07PHASE12024-08-282026-07
NCT05650879ELVN-002 in HER2 Mutant Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-07PHASE12023-03-202026-07
NCT03519945A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)RECRUITING2026-07PHASE32018-07-182027-12
NCT03118505A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal ConditionsACTIVE_NOT_RECRUITING2026-07NA2017-06-292026-12
NCT06470451Confirmatory Study of Topical HyBryteâ„¢ vs. Placebo for the Treatment of CTCLRECRUITING2026-07PHASE32025-01-072026-10
NCT07108153Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to TrikaftaNOT_YET_RECRUITING2026-07PHASE22025-102026-07
NCT06084481Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400RECRUITING2026-07PHASE12023-11-092026-07
NCT05552755Evaluate REC-4881 in Patients With FAPRECRUITING2026-07PHASE1, PHASE22023-07-102026-07
NCT07159828A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid TumorsRECRUITING2026-07PHASE12025-09-152027-05-15
NCT04184050Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)ACTIVE_NOT_RECRUITING2026-06-30PHASE12020-04-132026-06-30
NCT06537999A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyRECRUITING2026-06-30PHASE22024-09-172028-03-31
NCT03706833Edwards PASCAL CLASP IID/IIF Pivotal Clinical TrialRECRUITING2026-06-30NA2018-11-302031-06-30
NCT06606847A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)ACTIVE_NOT_RECRUITING2026-06-30PHASE22024-09-242027-06-30
NCT04150497Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)RECRUITING2026-06-30PHASE1, PHASE22019-10-142026-06-30
NCT05221840A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-06-30PHASE32022-02-072030-07-02
NCT06851806Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) DiseaseNOT_YET_RECRUITING2026-06-30NA2025-08-302026-06-30
NCT06637423A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)RECRUITING2026-06-30PHASE1, PHASE22024-12-202028-07-31
NCT05825365Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, Phaseâ…¡, Double-Blinded, Placebo-Controlled StudyWITHDRAWN2026-06-30PHASE22023-08-312026-06-30
NCT06049212Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)RECRUITING2026-06-30PHASE12023-10-262027-01-29
NCT04939610A Study of 177Lu-FAP-2286 in Advanced Solid TumorsRECRUITING2026-06-30PHASE1, PHASE22021-07-302028-06-30
NCT04524000Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast CancerACTIVE_NOT_RECRUITING2026-06-30PHASE22021-01-082026-07-31
NCT04925479Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid LeukemiaRECRUITING2026-06-30PHASE1, PHASE22021-12-272031-11-01
NCT06016738OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerRECRUITING2026-06-30PHASE32023-11-162027-09-30
NCT04855656Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid TumorsRECRUITING2026-06-30PHASE12021-04-302026-12-31
NCT05911295Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2RECRUITING2026-06-30PHASE32023-09-222029-04-30
NCT05818683A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate CancerRECRUITING2026-06-30PHASE12023-04-262027-09-01
NCT05511922PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 TrialACTIVE_NOT_RECRUITING2026-06-30PHASE32022-10-242026-06-30
NCT04406727UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 InfectionNOT_YET_RECRUITING2026-06-30PHASE32023-12-012026-06-30
NCT05701800A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of AgeACTIVE_NOT_RECRUITING2026-06-30PHASE1, PHASE22023-01-232026-06-30
NCT05920356A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)RECRUITING2026-06-30PHASE32023-11-162031-06-30
NCT05505916An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)ACTIVE_NOT_RECRUITING2026-06-30PHASE32022-10-242026-06-30
NCT05208944THIO Sequenced With Cemiplimab in Advanced NSCLCRECRUITING2026-06-30PHASE22022-06-082026-12-31
NCT03742895Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)ACTIVE_NOT_RECRUITING2026-06-30PHASE22018-12-122026-06-30
NCT04925024Evaluation of Lomecel-Bâ„¢ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.ACTIVE_NOT_RECRUITING2026-06-30PHASE22021-06-252026-08-31
NCT06308120A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENBRECRUITING2026-06-30NA2024-03-202026-09-30
NCT04892173JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCRECRUITING2026-06-30PHASE32022-01-042027-12-31
NCT06407934A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisRECRUITING2026-06-29PHASE32024-05-082027-04-05
NCT07074327Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy ParticipantsRECRUITING2026-06-29PHASE12025-07-112026-07-04
NCT03813407An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRECRUITING2026-06-29PHASE32019-04-022026-06-29
NCT05440708A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaRECRUITING2026-06-29PHASE1, PHASE22023-03-232027-06-28
NCT04906460Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)RECRUITING2026-06-27PHASE1, PHASE22021-09-282027-04-24
NCT06785012A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderRECRUITING2026-06-26PHASE22024-12-262026-06-26
NCT05265273A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia GravisRECRUITING2026-06-26PHASE2, PHASE32022-07-202026-06-26
NCT05021835ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationACTIVE_NOT_RECRUITING2026-06-26PHASE32021-08-302026-06-26
NCT06372925Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial InfarctionRECRUITING2026-06-24PHASE42024-07-122026-06-24
NCT03975829Pediatric Long-Term Follow-up and Rollover StudyACTIVE_NOT_RECRUITING2026-06-23PHASE42019-11-042026-07-23
NCT07034690Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With DyslipidemiaNOT_YET_RECRUITING2026-06-23PHASE42025-06-302027-06-30
NCT06698042A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)RECRUITING2026-06-22PHASE32024-11-212030-02-11
NCT04640025A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of ItacitinibACTIVE_NOT_RECRUITING2026-06-22PHASE22021-03-102026-06-22
NCT05624450Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenRECRUITING2026-06-19PHASE32022-12-132026-06-19
NCT06028230A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaACTIVE_NOT_RECRUITING2026-06-19PHASE22023-09-292026-07-17
NCT06104124A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease ActivityACTIVE_NOT_RECRUITING2026-06-18PHASE32024-01-242026-08-19
NCT07105722A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of AgeRECRUITING2026-06-18PHASE12025-08-122026-06-18
NCT06862791A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs AloneACTIVE_NOT_RECRUITING2026-06-18PHASE22025-02-182026-06-18
NCT05600777A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughRECRUITING2026-06-17PHASE32022-12-052027-03-23
NCT06188520A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid TumorsRECRUITING2026-06-17PHASE1, PHASE22023-12-052026-06-17
NCT05731128A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))RECRUITING2026-06-17PHASE22023-01-122027-03-24
NCT05543616A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenRECRUITING2026-06-16PHASE2, PHASE32022-09-232026-06-16
NCT04185883Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)RECRUITING2026-06-16PHASE12019-12-172027-12-05
NCT04208178Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA MutationACTIVE_NOT_RECRUITING2026-06-16PHASE32020-07-162026-06-16
NCT05742802Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).RECRUITING2026-06-16PHASE32023-03-062026-08-17
NCT05851443A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe AsthmaRECRUITING2026-06-15PHASE22023-07-112027-01-31
NCT07153146Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.NOT_YET_RECRUITING2026-06-15PHASE12025-09-082026-06-15
NCT05424822A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)ACTIVE_NOT_RECRUITING2026-06-12PHASE12022-08-182027-07-30
NCT07045701FMXIN002 in Patients at Risk of AnaphylaxisENROLLING_BY_INVITATION2026-06-12PHASE2, PHASE32025-06-122026-07-12
NCT06450197Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseRECRUITING2026-06-12PHASE22024-08-282027-08-02
NCT05714969A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)RECRUITING2026-06-11PHASE22023-03-212026-06-11
NCT06417814A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerRECRUITING2026-06-11PHASE32024-10-042028-05-29
NCT05750628Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaRECRUITING2026-06-09PHASE22024-01-232026-06-23
NCT06821750A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy AdultsRECRUITING2026-06-09PHASE12025-02-112026-06-09
NCT06970405Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal WomenWITHDRAWN2026-06-08PHASE12025-05-292026-06-08
NCT06299111A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)RECRUITING2026-06-08PHASE22024-09-202026-06-08
NCT06384820Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)WITHDRAWN2026-06-08PHASE22024-11-142030-05-06
NCT06004661Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal FunctionRECRUITING2026-06-05PHASE22024-04-042026-08-04
NCT06973291A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque PsoriasisRECRUITING2026-06-05PHASE32025-07-092026-07-03
NCT03584165Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis PigmentosaENROLLING_BY_INVITATION2026-06-04PHASE32018-06-042026-06-04
NCT06965465A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy AdultsRECRUITING2026-06-04PHASE12025-06-202026-06-04
NCT04077463A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-06-03PHASE12019-09-042026-06-03
NCT06312020A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeRECRUITING2026-06-02PHASE22024-05-092027-02-09
NCT06534411A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothACTIVE_NOT_RECRUITING2026-06-02PHASE32024-11-052026-07-14
NCT07017725A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune ThrombocytopeniaRECRUITING2026-06-01PHASE1, PHASE22025-01-032026-12-30
NCT06859073A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaRECRUITING2026-06-01PHASE12024-11-132026-06-01
NCT07198139A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain VirusNOT_YET_RECRUITING2026-06-01PHASE1, PHASE22025-11-012026-10-01
NCT05853458Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM PredictorsACTIVE_NOT_RECRUITING2026-06-01PHASE42023-07-282027-01-27
NCT07086079A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)RECRUITING2026-06-01PHASE12025-09-262026-06-01
NCT06239467First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast CancerRECRUITING2026-06-01PHASE12024-02-262027-08-01
NCT06064929A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years OldRECRUITING2026-06-01PHASE1, PHASE22023-11-012026-06-01
NCT05701306APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid TumorsRECRUITING2026-06-01PHASE12023-02-282027-12-31
NCT056295594D-310 in Adults With Fabry Disease and Cardiac InvolvementRECRUITING2026-06PHASE1, PHASE22022-10-162030-06
NCT06603077A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis SuppurativaRECRUITING2026-06PHASE22024-09-162026-07
NCT03257033Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCRECRUITING2026-06PHASE32018-03-122026-09
NCT06127199Contraceptive Efficacy Study of OvapreneRECRUITING2026-06NA2023-12-192026-09
NCT065535474-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 YrsRECRUITING2026-06PHASE22024-07-242026-06
NCT045171494D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)ACTIVE_NOT_RECRUITING2026-06PHASE1, PHASE22020-06-092029-05
NCT06998056Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic DermatitisRECRUITING2026-06PHASE22025-06-092026-06
NCT05900908Post-operative Adjuvant Therapy w/wo GammaTile + Systemic TherapyWITHDRAWN2026-06PHASE42025-052028-06
NCT06603571A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 DiabetesACTIVE_NOT_RECRUITING2026-06PHASE22024-09-202026-08
NCT04708834Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive DisorderENROLLING_BY_INVITATION2026-06PHASE32021-03-302026-06
NCT05281471Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)RECRUITING2026-06PHASE32022-08-312026-10
NCT04905693Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseENROLLING_BY_INVITATION2026-06PHASE32022-09-062026-06
NCT06759389The VENTOR Clinical StudyRECRUITING2026-06NA2025-04-042026-06
NCT05280093HEAL-IST IDE TrialRECRUITING2026-06NA2022-05-312027-06
NCT06587282PREEMIE: Study for Treatment of PDA in Premature InfantsRECRUITING2026-06NA2025-03-062026-06
NCT06739811Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)RECRUITING2026-06NA2025-03-262027-01
NCT06081894Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCMRECRUITING2026-06PHASE32023-08-302026-09
NCT06347016Study of Plozasiran in Adults With Severe HypertriglyceridemiaACTIVE_NOT_RECRUITING2026-06PHASE32024-07-232026-09
NCT06382155A Phase 2 Study of Vosoritide in Children with Idiopathic Short StatureRECRUITING2026-06PHASE22024-10-212036-12
NCT03715933Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including SarcomasRECRUITING2026-06PHASE12018-10-102026-12
NCT06210945Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic SclerosisSUSPENDED2026-06PHASE22024-092026-12
NCT07035990Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.RECRUITING2026-06PHASE12025-07-232026-06
NCT06480565A Phase 1/2 Trial of ADI-270 in ccRCCACTIVE_NOT_RECRUITING2026-06PHASE1, PHASE22024-12-122027-06
NCT06347003Study of Plozasiran (ARO-APOC3) in Adults With Severe HypertriglyceridemiaACTIVE_NOT_RECRUITING2026-06PHASE32024-07-222026-09
NCT06901505To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisRECRUITING2026-06PHASE32025-07-242026-06
NCT05585320A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITING2026-06PHASE1, PHASE22022-10-312027-06
NCT06419205A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GWITHDRAWN2026-06PHASE22024-06-272026-06
NCT06698939ORKA-001 in Healthy VolunteersACTIVE_NOT_RECRUITING2026-06PHASE12024-12-192026-06
NCT06060665Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)ACTIVE_NOT_RECRUITING2026-06PHASE32023-09-052026-06
NCT04567550RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)ACTIVE_NOT_RECRUITING2026-06PHASE22020-11-202026-12
NCT06625320Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)RECRUITING2026-06PHASE32024-10-162027-12
NCT04768972FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)ACTIVE_NOT_RECRUITING2026-06PHASE32021-06-142028-03
NCT05547464Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated VolunteersRECRUITING2026-06PHASE1, PHASE22023-07-312027-05
NCT06843590A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic HypersomniaRECRUITING2026-06PHASE22025-05-222026-06
NCT07012395A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisRECRUITING2026-06PHASE22025-05-272028-03
NCT06365853A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha ExpressionRECRUITING2026-06PHASE22024-07-292027-06
NCT03911505ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPDRECRUITING2026-06PHASE32020-02-132026-06
NCT06982963Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac DiseaseRECRUITING2026-06PHASE22025-08-042026-06
NCT05462106A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)RECRUITING2026-06PHASE1, PHASE22022-06-212026-06
NCT07073170A Study of LY3549492 in Chinese Participants With Type 2 Diabetes MellitusNOT_YET_RECRUITING2026-06PHASE12025-082026-06
NCT06739122A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)RECRUITING2026-06PHASE32025-01-102026-07
NCT06749054Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and ChildrenRECRUITING2026-06PHASE22025-03-262026-12
NCT06310291VTP-1000 in Adults With Celiac DiseaseRECRUITING2026-06EARLY_PHASE12024-08-012026-06
NCT06568042Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyRECRUITING2026-06PHASE22024-08-222026-09
NCT06692283A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASHWITHDRAWN2026-06PHASE32025-032027-06
NCT06927999An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous UrticariaRECRUITING2026-06PHASE22025-07-092026-06
NCT04663308A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)ACTIVE_NOT_RECRUITING2026-06PHASE22020-12-182027-04
NCT05599984Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid TumorsRECRUITING2026-06PHASE12022-12-052026-06
NCT03406611Pegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)ACTIVE_NOT_RECRUITING2026-06PHASE1, PHASE22019-01-222026-12
NCT07019922A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and SafetyRECRUITING2026-06PHASE32025-08-132028-12
NCT05611632Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical TrialACTIVE_NOT_RECRUITING2026-06NA2021-08-312030-07
NCT06018428A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)RECRUITING2026-06PHASE22023-09-122026-09
NCT04626518Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)ACTIVE_NOT_RECRUITING2026-05-31PHASE1, PHASE22020-12-172026-05-31
NCT05339126RNS System LGS Feasibility StudyRECRUITING2026-05-31PHASE22022-10-042026-12-31
NCT06940440IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)NOT_YET_RECRUITING2026-05-31PHASE12025-04-302028-05-31
NCT04626479Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)ACTIVE_NOT_RECRUITING2026-05-31PHASE1, PHASE22020-12-162026-05-31
NCT06991270OMNI 3.1 Surgical System in Subjects With Primary Open-Angle GlaucomaRECRUITING2026-05-31NA2025-10-312026-05-31
NCT05312879Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney DiseaseRECRUITING2026-05-31PHASE2, PHASE32022-03-302026-06-30
NCT04496349A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHLRECRUITING2026-05-31PHASE22021-07-122027-05-31
NCT06664619A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaRECRUITING2026-05-31PHASE32024-12-122026-05-31
NCT04817007A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)ACTIVE_NOT_RECRUITING2026-05-31PHASE1, PHASE22021-03-222026-05-31
NCT06003231A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2ACTIVE_NOT_RECRUITING2026-05-31PHASE22023-11-142028-05-31
NCT05919238Padeliporfin VTP Treatment for Unresectable Pancreatic AdenocarcinomaRECRUITING2026-05-30PHASE12024-05-152026-10-30
NCT05270668Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)ACTIVE_NOT_RECRUITING2026-05-30PHASE22022-03-292029-07-31
NCT06666699RIVOS Feasibility (MBO)WITHDRAWN2026-05-30NA2025-08-312026-05-30
NCT07142707A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With ObesityRECRUITING2026-05-30PHASE12025-09-032026-05-30
NCT05983068A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic DermatitisACTIVE_NOT_RECRUITING2026-05-29PHASE42024-02-222026-08-07
NCT07207408Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of AgeRECRUITING2026-05-29PHASE22025-09-112026-10-16
NCT03847428Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative TreatmentACTIVE_NOT_RECRUITING2026-05-29PHASE32019-04-292027-05-31
NCT05379985Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRECRUITING2026-05-29PHASE12022-05-312026-06-30
NCT03701334A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerACTIVE_NOT_RECRUITING2026-05-29PHASE32018-12-072026-05-29
NCT05791201A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 DiabetesACTIVE_NOT_RECRUITING2026-05-29PHASE1, PHASE22023-05-162026-05-29
NCT06907511Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and OlderACTIVE_NOT_RECRUITING2026-05-28PHASE1, PHASE22025-04-172026-05-28
NCT05918250mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)WITHDRAWN2026-05-27PHASE12023-08-152026-05-27
NCT06130553A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid TumorsRECRUITING2026-05-27PHASE1, PHASE22024-01-182026-05-27
NCT06878404A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic ArthritisRECRUITING2026-05-27PHASE32025-02-212028-11-21
NCT06252285Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and ToddlersACTIVE_NOT_RECRUITING2026-05-27PHASE32024-02-062027-12-07
NCT05095727A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)RECRUITING2026-05-26PHASE1, PHASE22022-06-012028-12-26
NCT06241118A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK InhibitorRECRUITING2026-05-25PHASE32024-02-292026-09-14
NCT06666491An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and OlderRECRUITING2026-05-25PHASE32024-11-132026-05-25
NCT06685835A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)RECRUITING2026-05-22PHASE22024-12-162027-01-28
NCT05076175A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRECRUITING2026-05-22PHASE2, PHASE32022-05-302031-08-14
NCT04779320A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)RECRUITING2026-05-22PHASE32022-04-302026-05-22
NCT07072728Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderRECRUITING2026-05-21PHASE22025-09-152026-08-21
NCT04938817Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)RECRUITING2026-05-20PHASE1, PHASE22021-08-192029-12-10
NCT03937154Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerRECRUITING2026-05-20PHASE32020-02-262027-05-20
NCT06444113Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple SclerosisRECRUITING2026-05-18PHASE42024-11-252027-02-23
NCT05280548A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry DiseaseACTIVE_NOT_RECRUITING2026-05-15PHASE32022-05-032027-12-06
NCT06555419A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRxâ„¢ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)RECRUITING2026-05-15PHASE12025-01-162026-05-15
NCT06685185A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 DiabetesRECRUITING2026-05-15PHASE12024-11-122026-05-15
NCT05399888A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of AgeACTIVE_NOT_RECRUITING2026-05-14PHASE22022-08-242029-01-08
NCT06194825EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid CardiomyopathyACTIVE_NOT_RECRUITING2026-05-14PHASE32023-12-012027-01-05
NCT06616415A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic TherapiesACTIVE_NOT_RECRUITING2026-05-13PHASE42024-12-042026-05-13
NCT06299098A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass PreservationACTIVE_NOT_RECRUITING2026-05-13PHASE22024-03-132026-11-04
NCT03374657A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis PigmentosaACTIVE_NOT_RECRUITING2026-05-11PHASE1, PHASE22018-08-222026-05-11
NCT06625177A Trial to Test the Safety and Efficacy of TEV-53408 in Treating VitiligoRECRUITING2026-05-09PHASE12024-11-112027-06-05
NCT06137144AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.RECRUITING2026-05-08PHASE1, PHASE22024-01-232026-05-08
NCT06806046Anti-CEACAM5 ADC M9140 in Chinese Participants With Solid Tumors (PROCEADE-CRC-02)RECRUITING2026-05-07PHASE12024-12-202026-05-07
NCT06550076A Study of TAK-279 in Participants With Moderate-to-Severe Plaque PsoriasisRECRUITING2026-05-07PHASE32024-09-042026-05-07
NCT06448247A Study of SPY001-001 in Healthy VolunteersACTIVE_NOT_RECRUITING2026-05-05PHASE12024-06-062026-05-05
NCT06239116A Study of RM-718 in Healthy Subjects and in Patients With HORECRUITING2026-05-04PHASE12024-03-052026-05-04
NCT06681324Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an IleostomyRECRUITING2026-05-04PHASE22024-12-112027-06-18
NCT06649630A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy MenRECRUITING2026-05-04PHASE12024-09-232026-05-04
NCT06829823Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder CancerNOT_YET_RECRUITING2026-05-01PHASE22025-05-012029-05-01
NCT06944717A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years OldACTIVE_NOT_RECRUITING2026-05-01PHASE12025-03-032026-05-01
NCT06228924Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCRECRUITING2026-05-01PHASE12024-03-262029-10-01
NCT04790344LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.ACTIVE_NOT_RECRUITING2026-05NA2021-03-202026-06
NCT05934097FT596 in Combination With R-CHOP in Subjects With B-Cell LymphomaWITHDRAWN2026-05PHASE12022-122039-05
NCT05732831Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsRECRUITING2026-05PHASE1, PHASE22023-05-262026-09
NCT06170606POLARx Post Approval Study (POLARx PAS)RECRUITING2026-05NA2024-06-282029-05
NCT05610891Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGGACTIVE_NOT_RECRUITING2026-05PHASE12023-10-012026-09
NCT05329649Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)RECRUITING2026-05PHASE32022-05-022026-05
NCT06347133Phase 3 Study of Plozasiran in Adults With HypertriglyceridemiaACTIVE_NOT_RECRUITING2026-05PHASE32024-05-212026-09
NCT05356195Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)RECRUITING2026-05PHASE32022-05-032026-05
NCT07082816Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionRECRUITING2026-05PHASE32025-09-022026-05
NCT06687070APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced STRECRUITING2026-05PHASE12024-12-172027-05
NCT06493383Lotrafilcon B Plano Cosmetic Contact Lenses StudyWITHDRAWN2026-05NA2025-012026-05
NCT05929079A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or OverweightACTIVE_NOT_RECRUITING2026-05PHASE32023-07-112026-05
NCT06816992ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLCRECRUITING2026-05PHASE12025-02-272027-05
NCT05125302Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)RECRUITING2026-05PHASE32022-01-132026-05
NCT05101096Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-05PHASE1, PHASE22021-10-202026-05
NCT06885177TECTONIC CAD IVL IDE StudyRECRUITING2026-05NA2025-04-012028-06
NCT05874414Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated CholangiocarcinomaRECRUITING2026-05PHASE1, PHASE22023-08-212026-10
NCT06047548A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesACTIVE_NOT_RECRUITING2026-05PHASE32023-09-202026-05
NCT06924970A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)RECRUITING2026-05PHASE22025-05-012027-05
NCT05182697SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)RECRUITING2026-05NA2024-02-212026-06
NCT06075667A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesACTIVE_NOT_RECRUITING2026-05PHASE32023-10-162029-07
NCT04819100A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)ACTIVE_NOT_RECRUITING2026-05PHASE32021-12-202028-05
NCT06513312Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)ACTIVE_NOT_RECRUITING2026-05PHASE22024-10-072028-12
NCT06058013Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderRECRUITING2026-05PHASE32023-12-202026-06
NCT05424484Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia OccurrenceACTIVE_NOT_RECRUITING2026-05NA2022-11-222028-09
NCT05546268Study of Oral MRT-2359 in Selected Cancer PatientsRECRUITING2026-05PHASE1, PHASE22022-10-122027-11
NCT04248439Gene Therapy for Fanconi Anemia, Complementation Group AACTIVE_NOT_RECRUITING2026-05PHASE22020-07-152026-05
NCT05718557Study of PYX-106 in Solid TumorsACTIVE_NOT_RECRUITING2026-05PHASE12023-05-232026-05
NCT07044674A Cataract Surgery Clinical TrialNOT_YET_RECRUITING2026-05NA2026-022026-06
NCT03105102A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's DiseaseACTIVE_NOT_RECRUITING2026-05PHASE32018-04-092026-05
NCT05965167Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous ForteoACTIVE_NOT_RECRUITING2026-05PHASE1, PHASE22023-05-112026-05
NCT04624698iStent Inject New Enrollment Post-Approval StudyACTIVE_NOT_RECRUITING2026-05NA2020-09-222026-05
NCT06982846A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to HypoglycemiaRECRUITING2026-05PHASE12025-06-062026-05
NCT06005792Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic DermatitisACTIVE_NOT_RECRUITING2026-05PHASE12022-10-102026-05
NCT05645107A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin LymphomaRECRUITING2026-05PHASE32022-12-262026-06
NCT07177066A Study of EDG-15400 in Healthy AdultsRECRUITING2026-05PHASE12025-08-202026-05
NCT05784246A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative ColitisRECRUITING2026-05PHASE32023-11-222026-08
NCT07136103A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult ParticipantsRECRUITING2026-05PHASE12025-08-192026-05
NCT03952078A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell LymphomaACTIVE_NOT_RECRUITING2026-04-30PHASE12019-05-032026-04-30
NCT04612751Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-04-30PHASE12021-02-022026-04-30
NCT06619860Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral NeuropathyRECRUITING2026-04-30PHASE22024-10-182026-05-30
NCT05203510A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial HypertensionACTIVE_NOT_RECRUITING2026-04-30PHASE42022-10-202028-04-30
NCT06897748A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated EosinophilsRECRUITING2026-04-30PHASE22025-04-122026-04-30
NCT04960709Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse CisplatinACTIVE_NOT_RECRUITING2026-04-30PHASE32021-08-052028-09-08
NCT06040541Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsRECRUITING2026-04-30PHASE12023-09-072027-04-30
NCT05156281Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)RECRUITING2026-04-30PHASE32021-12-132030-10-30
NCT04494412An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza InfectionRECRUITING2026-04-30PHASE22022-11-212026-04-30
NCT05166161A Long-Term Safety Study of PTC923 in Participants With PhenylketonuriaRECRUITING2026-04-30PHASE32022-02-142026-04-30
NCT06639451A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)RECRUITING2026-04-30NA2024-12-132026-12-31
NCT05153317Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and OlderACTIVE_NOT_RECRUITING2026-04-30PHASE32022-01-172026-04-30
NCT05085366A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of AgeACTIVE_NOT_RECRUITING2026-04-30PHASE32021-10-262028-04-30
NCT07024823A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional CohortRECRUITING2026-04-30PHASE12025-06-092026-04-30
NCT05060016A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)ACTIVE_NOT_RECRUITING2026-04-30PHASE22021-12-012027-04-30
NCT06676072A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:RECRUITING2026-04-30NA2024-11-222026-04-30
NCT06510777PICO Venous Leg Ulcers (VLU) Reimbursement StudySUSPENDED2026-04-30NA2023-12-292026-04-30
NCT05147220Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)RECRUITING2026-04-30PHASE32021-12-162030-10-30
NCT06602193Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)RECRUITING2026-04-30PHASE22024-10-242028-02-28
NCT06890923Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisRECRUITING2026-04-30PHASE22025-03-042026-08-30
NCT05245500Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionRECRUITING2026-04-30PHASE12022-06-092026-04-30
NCT06223958Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular DegenerationACTIVE_NOT_RECRUITING2026-04-29PHASE32024-01-292027-09-27
NCT06422689Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine CareRECRUITING2026-04-29PHASE42024-05-102026-04-29
NCT03682068Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial CancerACTIVE_NOT_RECRUITING2026-04-29PHASE32018-09-272026-04-29
NCT07168356A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney DiseaseNOT_YET_RECRUITING2026-04-28PHASE12025-09-162026-08-18
NCT05488314A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-04-27PHASE1, PHASE22022-12-132026-04-27
NCT06213506A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and InfantsRECRUITING2026-04-27PHASE22024-01-152026-04-27
NCT05653349Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)ACTIVE_NOT_RECRUITING2026-04-24PHASE32023-03-062028-12-18
NCT06208150A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomideRECRUITING2026-04-23PHASE32024-01-222027-06-27
NCT06154447Evaluation of VX-828 in Healthy Participants and in Participants With Cystic FibrosisRECRUITING2026-04-23PHASE12023-12-122026-04-23
NCT04696809A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITING2026-04-22PHASE1, PHASE22021-02-222026-04-22
NCT05675449A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple MyelomaRECRUITING2026-04-22PHASE12022-12-142028-02-29
NCT06589713Effect of Renal Impairment on Enpatoran PharmacokineticsRECRUITING2026-04-22PHASE12024-09-242026-04-22
NCT06388187A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose WeightACTIVE_NOT_RECRUITING2026-04-21PHASE32024-06-242026-04-21
NCT05849844Tympanoseal Clinical StudyRECRUITING2026-04-20NA2024-01-052026-04-20
NCT04305054Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)ACTIVE_NOT_RECRUITING2026-04-20PHASE1, PHASE22020-07-012026-04-20
NCT06672523A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase DeletionRECRUITING2026-04-20PHASE12025-03-242026-04-20
NCT05712356A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-04-18PHASE22023-08-242030-03